Hayfin Expects Private-Debt M&A; BI on Ozempic Risks

Hayfin Expects Private-Debt M&A; BI on Ozempic Risks

0 Recensioner
0
Episod
51 of 144
Längd
33min
Språk
Engelska
Format
Kategori
Ekonomi & Business

Private-debt firms are set to consolidate as larger companies dominate deal flow, according to Marc Chowrimootoo, portfolio manager at Hayfin Capital Management. “We’re seeing a concentration within fewer hands,” Chowrimootoo tells Bloomberg News’ Lisa Lee and James Crombie and Bloomberg Intelligence’s Julie Hung in the latest Credit Edge podcast. “That trend is going to continue.” He identifies debt refinancing as the big opportunity for private lenders in 2024. Hayfin likes the health-care and software sectors, while avoiding smaller borrowers that are struggling with higher rates. In addition, BI’s Hung weighs the impact on food and drink companies of weight-loss drugs like Ozempic.

See omnystudio.com/listener for privacy information.


Lyssna när som helst, var som helst

Kliv in i en oändlig värld av stories

  • 1 miljon stories
  • Hundratals nya stories varje vecka
  • Få tillgång till exklusivt innehåll
  • Avsluta när du vill
Starta erbjudandet
SE - Details page - Device banner - 894x1036
Cover for Hayfin Expects Private-Debt M&A; BI on Ozempic Risks

Andra podcasts som du kanske gillar...